Central venous catheters up infection risk in cancer patients

July 3, 2014
Central venous catheters up infection risk in cancer patients

(HealthDay)—Long-term central venous catheters (CVCs) are associated with an increased risk of infection in older adults with cancer, according to research published online June 30 in the Journal of Clinical Oncology.

Allison Lipitz-Snyderman, Ph.D., of the Memorial Sloan Kettering Cancer Center in New York City, and colleagues analyzed data from 2005 to 2007 for patients diagnosed with invasive or noninvasive breast cancer; invasive colorectal, head and neck, lung, or pancreatic cancer; or non-Hodgkin's lymphoma. All patients were older than 65 years. The authors sought to assess the effect of long-term CVC use on infection risk.

The researchers found that CVC use was associated with significantly increased risk of infection among older patients with cancer. During CVC exposure, increased risk of infection was observed among patients with breast cancer (adjusted hazard ratio [aHR], 6.19; 95 percent confidence interval [CI], 5.42 to 7.07) or (aHR, 2.93; 95 percent CI, 2.58 to 3.33). The same associations were found after adjusting for propensity to receive a CVC and limiting the cohort to only include individuals at high risk of infections.

"Careful assessment of the need for long-term CVCs and targeted strategies for reducing infections are critical to improving cancer care quality," the authors write.

Explore further: Diet may affect risk recurrence of some breast cancers

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Diet may affect risk recurrence of some breast cancers

June 20, 2014
(HealthDay)—Personalized dietary recommendations based on molecular characteristics of primary tumor tissue may be an effective strategy for breast cancer survivors, according to research published in the July issue of ...

Metformin use doesn't cut incidence of bladder cancer

February 11, 2014
(HealthDay)—For patients with type 2 diabetes, metformin use is not associated with a significantly reduced risk of bladder cancer, according to a study published online Feb. 4 in Diabetes Care.

Statins may reduce risk of progression of renal cancer

April 23, 2014
(HealthDay)—Use of statins is associated with a reduced risk of progression of localized renal cell carcinoma, according to research published in the April issue of The Journal of Urology.

Review IDs modifiers of cancer risk in BRCA1/2 carriers

May 23, 2014
(HealthDay)—Modifiers of cancer risk have been identified for BRCA1/2 mutation carriers, according to a review published online May 13 in the Journal of the National Cancer Institute.

Pill effects on breast, ovarian CA same in high-risk women

October 22, 2013
(HealthDay)—Among women who are BRCA1/2 mutation carriers, the associations between ever use of oral contraceptives (OCs) and ovarian and breast cancers are similar to those observed in the general population, according ...

Risk of unnatural death is higher in diabetes patients

June 5, 2014
(HealthDay)—Unnatural deaths occur more frequently among individuals with diabetes, according to research published online May 21 in Diabetes Care.

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.